Service

CAP Biorepository Accreditation Consulting

CAP biorepository accreditation is the College of American Pathologists' accreditation of a biorepository that receives, stores, processes and distributes biospecimens and data for research, inspected on site every two years against CAP checklists. This page is for research and healthcare organizations that are setting up a repository or preparing for a first CAP inspection. Integral Healthcare Solutions (IHS) drafts the repository's governance and documentation procedures for CAP accreditation; your scientists own preservation methods and biosafety.

Last reviewed: October 2026.

What is CAP biorepository accreditation?

CAP's Biorepository Accreditation Program began in 2012, and CAP presents it as the first accreditation program of its kind for biorepositories (CAP Biorepository Accreditation Program). It is one of several CAP programs, alongside the Laboratory Accreditation Program, CAP 15189, Forensic Drug Testing and Reproductive programs (CAP accreditation).

The governing text is the CAP checklist set for the program. CAP's program page names four checklists, Biorepository, Laboratory General, Director Assessment and All Common, which participants reach through CAP's customer portal, e-LAB Solutions Suite (CAP). Checklists sit behind that portal, so the checklist edition you purchase is the version of record for your preparation. IHS works from your copy.

The program page sets the inspection cycle at an on-site inspection every two years against the CAP accreditation checklists, with a self-inspection by the repository in the off year (CAP).

Who needs it and what triggers it

CAP aims this program at research biorepositories, and its program page carries the full eligibility description (CAP). The work usually starts with one of these events:

CLIA is a separate question. CLIA's rules exclude "Research laboratories that test human specimens but do not report patient specific results for the diagnosis, prevention or treatment of any disease or impairment of, or the assessment of the health of individual patients" (42 CFR 493.3(b)(2)). IHS's reading, as of October 2026: a repository that only stores and distributes specimens for research, and reports no patient-specific results, will often fall outside CLIA, which makes CAP biorepository accreditation a voluntary quality credential rather than a federal certificate. Whether your repository is inside or outside CLIA depends on what it does, and this page does not decide that for you.

How IHS helps

IHS markets a process, applied to the CAP biorepository checklist set you hold:

  1. Gap assessment against the Biorepository, Laboratory General, Director Assessment and All Common checklists.
  2. Questionnaires on specimen receipt, transfer, inventory and deviations, so the gaps are found in your own words and records.
  3. Document and evidence mapping: a crosswalk from each checklist requirement to the procedure, record or log that shows it is met.
  4. Drafting the specimen governance, chain-of-custody, inventory and deviation procedures for your repository scientists to review and approve.
  5. Mock inspection document review before the CAP inspection, using the same checklists.
  6. Readiness support while you prepare your application, through the inspection and during the response to any deficiencies. You submit the application and the response.

What you supply: the purchased checklists, your current SOPs, access to your inventory systems, and the repository scientists who own preservation methods and biosafety.

The limit: preservation methods, biosafety and specimen fitness for use are scientific judgments. They stay with your scientists. IHS covers governance and documentation. Your organization applies to CAP and hosts the inspection; IHS does not apply on your behalf.

What to have ready

Printable version of this checklist (PDF)

How it compares

The routes below come from the sources' own pages. Which one fits depends on what your sponsors, collaborators and leadership expect.

RouteWhat the sources say
CAP Biorepository Accreditation ProgramOn-site inspection every two years against CAP checklists, with an off-year self-inspection (CAP).
ISO 20387 accreditation through A2LAA2LA accredits biobanks against ISO 20387, a standard on biobank competence and on supplying biological material and data for research. A2LA says it fits each assessment to the activities the biobank performs (A2LA, page opened October 3, 2026).
CAP readiness optionsA repository unsure of its readiness can buy the checklists and run a self-inspection, or ask CAP about its readiness assessment, CARA (CAP).
No accreditationIHS's reading (October 2026): available to a research-only repository outside CLIA under 42 CFR 493.3(b)(2), with no external quality credential to show sponsors or collaborators.
IHS gap assessment and draftingA crosswalk, drafted procedures and a mock document review against the checklists you hold. It does not replace your scientists or CAP's decision.

What it costs

CAP does not publish a fee schedule on the pages we reviewed, and fees depend on scope. CAP's biorepository program page refers to a one-time application fee without giving an amount (CAP). CAP's general accreditation process page directs applicants to a fee estimate form for cost information and says the application fee is waived when the checklists are purchased and the application follows within six months (CAP accreditation process, page opened October 3, 2026). That page describes the general process, so confirm with CAP whether the waiver applies to a biorepository application. Verify current fees with CAP. IHS scopes each engagement after a free introductory call.

What this is not

Frequently asked questions

What is CAP biorepository accreditation?

It is the College of American Pathologists' accreditation program for biorepositories, established in 2012. CAP aims the program at research biorepositories, and its program page carries the eligibility description. CAP inspects on site every two years against its checklists.

Does a research biobank need CAP accreditation, or is it voluntary?

IHS's reading, as of October 2026, is that CAP presents the program as an accreditation a repository may seek, and the pages we reviewed do not say a repository must hold it. IHS's reading, as of October 2026, is that a research-only repository that reports no patient-specific results will often fall outside CLIA, which would make CAP accreditation voluntary for it. Whether that holds depends on what your repository does.

Is a research-only biorepository subject to CLIA?

CLIA's rules at 42 CFR 493.3(b)(2) exclude research laboratories that test human specimens but do not report patient-specific results for diagnosis, prevention, treatment or the assessment of an individual patient's health. A repository that does report such results is a different case. This page does not decide which side your repository is on.

What checklists does CAP use to inspect a biorepository?

CAP's program page names four checklists: Biorepository, Laboratory General, Director Assessment and All Common. Participants reach them through CAP's customer portal, e-LAB Solutions Suite. The edition you purchase is the one to prepare against.

How long does it take to get CAP biorepository accreditation after applying?

CAP's general accreditation process page shows a timeframe of 13 to 24 weeks beside its application-to-inspection steps. That page does not say whether the range applies to the biorepository program specifically, so confirm it with CAP for your application.

How often is a CAP-accredited biorepository inspected?

According to CAP's program page, on-site inspections come every two years against the CAP accreditation checklists. The repository does a self-inspection in the off year.

How much does CAP biorepository accreditation cost?

CAP refers to a one-time application fee but does not publish an amount on the pages we reviewed, and it directs applicants to a fee estimate form. CAP's accreditation process page says the fee is waived when the checklists are purchased and the application follows within six months, so confirm whether that applies to a biorepository. Verify current fees with CAP. IHS scopes its own work after a free introductory call.

Should a biobank choose CAP accreditation or ISO 20387?

Both exist. A2LA accredits biobanks against ISO 20387, a standard on biobank competence. CAP inspects against its own checklists every two years. The choice depends on what your sponsors, collaborators and leadership expect, and IHS does not make it for you.

Can we do a mock inspection or readiness assessment before applying?

Yes. CAP's program page points a repository unsure of its readiness to two routes, a self-inspection with purchased checklists or CAP's own readiness assessment, CARA. IHS runs a mock inspection document review against the checklists you hold.

Does IHS write our scientific procedures or apply to CAP for us?

No. IHS drafts governance, chain-of-custody, inventory and deviation procedures for your repository scientists to approve. Preservation methods, biosafety and specimen fitness stay with your scientists, and your organization applies to CAP and hosts the inspection.

Recent changes

  • Clinical Laboratory Improvement Amendments: Use Updated Application for Certification

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS updated the Application for Certification (PDF) (form CMS-116) under the Clinical Laboratory Improvement Amendments (CLIA) . The revised form took effect on November 9.”

    Checked

  • Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities

    · Substance Abuse and Mental Health Services Administration

    Full title: Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies (Notice; FR Doc. 2026-22321)

    Substance Abuse and Mental Health Services Administration states: “The Department of Health and Human Services (HHS) provides notice of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.”

    Checked

  • REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment

    · Centers for Medicare & Medicaid Services

    Full title: REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits (QSO-18-14-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-18-14-CLIA, "Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits", on October 16, 2026.

    Checked

  • Clinical Laboratory Improvement Amendments: Provide Input on Proposed Changes by December 7

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS is seeking input on proposed changes to the rules implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Comment period, in the source's words: “Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Checked

  • REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance

    · Centers for Medicare & Medicaid Services

    Full title: REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance (QSO-23-15-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-23-15-CLIA, "REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance", on October 14, 2026.

    Checked

More: Laboratories · all standards changes

Talk with IHS's CEO

A 30-minute introductory meeting with Thomas G. Goddard, JD, PhD, to scope what your organization needs.

Schedule a Free Discovery Session